Receptos PT Raised to $31.00 at Credit Suisse (RCPT)
Stock analysts at Credit Suisse raised their price objective on shares of Receptos (NASDAQ:RCPT) from $21.00 to $31.00 in a report issued on Wednesday, AmericanBankingNews.com reports. The firm currently has an “outperform” rating on the stock. Credit Suisse’s price objective would indicate a potential downside of 6.68% from the company’s current price.
A number of other analysts have also recently weighed in on RCPT. Analysts at Wedbush reiterated a “buy” rating on shares of Receptos in a research note to investors on Wednesday. They now have a $19.39 price target on the stock. Separately, analysts at BMO Capital Markets raised their price target on shares of Receptos to $40.00 in a research note to investors on Wednesday.
Shares of Receptos (NASDAQ:RCPT) traded up 23.04% during mid-day trading on Wednesday, hitting $33.22. The stock had a trading volume of 1,710,147 shares. Receptos has a 52 week low of $13.00 and a 52 week high of $31.82. The stock has a 50-day moving average of $23.31 and a 200-day moving average of $19.39.
Receptos, Inc (NASDAQ:RCPT) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.